Addressing antimicrobial resistance in China: Policy implementation in a complex context

Globalization and Health

Volumn 12, Issue 1, 2016, Pages

  Wang, Li ^a,b   Zhang, Xiulan ^a   Liang, Xiaoyun ^a   Bloom, Gerald ^c  

^a BEIJING NORMAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Anti microbial resistance; Antibiotics; Complex adaptive system; Global public good; Incentive; Regulation

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; HEALTH POLICY; INCENTIVE; POLICY IMPLEMENTATION; PUBLIC GOODS; REGULATORY FRAMEWORK;

ADAPTIVE BEHAVIOR; ANTIBIOTIC RESISTANCE; ARTICLE; CHINA; DRUG MARKETING; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH PROGRAM; MEDICAL PRACTICE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; RISK REDUCTION; CLINICAL PRACTICE; HUMAN; LEGISLATION AND JURISPRUDENCE; PROCEDURES; SOCIAL CONTROL; STANDARDS;

CHINA;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; CHINA; DRUG RESISTANCE, MICROBIAL; HEALTH POLICY; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; SOCIAL CONTROL, FORMAL;

EID: 84973364278     PISSN: None     EISSN: 17448603     Source Type: Journal    
DOI: 10.1186/s12992-016-0167-7     Document Type: Article

References (71)

1. Ma J. 65 years for development: to celebrate the 65th anniversary of the founding of the People's Republic of China. People's Daily. Beijing: The People's Daily Press; 2014.
2. Cook IG, Dummer TJB. Changing health in China: re-evaluating the epidemiological transition model. Health Policy. 2004;67:329-43.
3. Otto C. Securing access to effective antibiotics for current and future generations. Whose responsibility? Ups J Med Sci. 2014;119:209-14.
4. Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States. Glob Health. 2006;2:6.
5. Xiao YH, Wang J, Li Y. Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005. Eur J Clin Microbiol Infect Dis. 2008;27:697-708.
6. Li Y, Xu J, Wang F, Wang B, Liu L, Hou W, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood). 2012;31:1075-82.
7. Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and Prescription of Antibiotics in Primary Health Care Settings in China. JAMA Intern Med. Published online October 06, 2014.doi: 10.1001/jamainternmed.2014.5214
8. Liang X, Jin C, Wang L, Wei L, Tomson G, Rehnberg C, et al. Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China. Int J Clin Pharm. 2011;33:750-4.
9. Xie D, Xiang L, Li R, Hu Q, Luo Q, Xiong W. A multicenter point-prevalence survey of antibiotic use in 13 Chinese hospitals. J Infection Public Health. 2014; Article in Press.
10. Jin C, Ely A, Fang L, Liang X. Framing a global health risk from the bottom-up User perceptions and practices around antibiotics in four villages in China. Health Risk Soc. 2011;13:433-9.
11. Li J, Qi H, Li Y. 2002-2003 Bacterial resistance surveillance on Gram-positive cocci isolated from hospital acquired infections and community acquired infections in China. Zhong Hua Jian Yan Yi Xue Za Zhi. 2005;28:254-65.
12. Xiao Y, Wang J, Zhao C, Gao L, Zheng B, Xue F, et al. Mohnarin Bacterial Resistance Surveillance 2006-2007. Zhong Hua Yi Yuan Gan Ran Xue Za Zhi. 2008;18:1051-6.
13. Xiao Y, Wang J, Zhu Y, Qi H, Li X, Zhao C, et al. Mohnarin of 2008:Surveillance Results of National Bacterial Drug Resistance. Zhong Hua Yi Yuan Gan Ran Xue Za Zhi. 2010;20:2377-83.
14. Xue F, Lv Y. Mohnarin report in 2009:Bacterial distribution and resistance in bloodstream infec-tions. Zhong Guo Lin Chuang Yao Li Xue Za Zhi. 2011;27:352-6.
15. Xiao Y, Shen P, Wei Z, Chen Y, Kong H, YANG Q, et al. Mohnarin report of 2011: monitoring of bacterial resistance in China. Zhong Hua Yi Yuan Gan Ran Xue Za Zhi. 2012;22:4946-52.
16. National Health and Family Planning Commision(NHFPC). Drafting note about guidelines for antibacterial use in clinical practice. 2004. http://www.nhfpc.gov.cn/zhuzhan/zcjd/201304/defe1384888d4d37b1ed17ed2373cb42.shtml. Accessed 15 Dec 2014.
17. National Health and Family Planning Commision(NHFPC). Answer questions about "Measures for the management of clinical application of antibacterial drugs" 2012. http://www.nhfpc.gov.cn/zhuzhan/zcjd/201304/43c21ad2846d4cd58785310fc1fc775a.shtml. Accessed 15 Dec 2014.
18. Regulations on antibiotics will cover all aspects. Jian Kang Bao. 2015; November 19.
19. Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057-98.
20. Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q, et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children's hospitals. Eur J Clin Pharmacol. 2008;64:821-8.
21. Gu X. Failure in price regulation and high medicine price. Zhong Gong Zhe Jiang Sheng Wei Dang Xiao Xue Bao. 2011;6:12-22.
22. Liang X, Xia T, Zhang X, Jin C. Governance structure reform and antibiotics prescription in community health centres in Shenzhen. China Fam Pract. 2014;31:311-8.
23. Tomson G, Vlad I. The need to look at antibiotic resistance from a health systems perspective. Ups J Med Sci. 2014;119:117-24.
24. Xiao Y, Zhao K, Bishai DM, Peters DH. Essential drugs policy in three rural counties in China: What does a complexity lens add? Soc Sci Med. 2013;93:220-8.
25. Sudhinaraset M, Ingram M, Lofthouse HK, Montagu D. What Is the Role of Informal Healthcare Providers in Developing Countries? A Systematic Review. PLoS One. 2013;8:2.
26. Paina L, Peters DH. Understanding pathways for scaling up health services through the lens of complex adaptive systems. Health Policy Plan. 2012;27:365-73.
27. Gatrell AC. Complexity theory and geographies of health: a critical assessment. Soc Sci Med. 2005;60:2661-71.
28. Lessard C. Complexity and reflexivity: Two important issues for economic evaluation in health care. Soc Sci Med. 2007;64:1754-65.
29. Lansing JS. Complex adaptive systems. Annu Rev Anthropol. 2003;32:183-204.
30. Crabtree BF, Reuben MD, Miller WL, Stange KC. Understanding change in primary care practice using complexity theory. J Fam Pract. 1998;46:369-79.
31. Lissack MR. Complexity the science its vocabulary and its relation to organizations. Emergence. 1999;1:110-27.
32. World Health Organization (WHO). Everybody's business-strenthening health system to improve health outcomes: WHO's framework for action. Geneva: World Health Organization (WHO); 2007.
33. Savigny D, Adam T. Systems thinking for health systems strengthening. Geneva: World Health Organization(WHO); 2009.
34. Leykum LK, Pugh J, Lawrence V, Parchman M, Noël PH, Cornell J, et al. Organizational interventions employing principles of complexity science have improved outcomes for patients with Type II diabetes. Implement Sci. 2007;2:28.
35. Boustani MA, Munger S, Gulati R, Vogel M, Beck RA, Callahan CM. Selecting a change and evaluating its impact on the performance of a complex adaptive health care delivery system. Clin Interv Aging. 2010;5:141-7.
36. Stroebel CK, McDaniel Jr RR, Crabtree BF, Miller WL, Nutting PA, Stange KC. How complexity science can inform a reflective process for improvement in primary care practices. Jt Comm J Qual Patient Saf. 2005;31:438-46.
37. Litaker D, Tomolo A, Liberatore V, Stange KC, Aron D. Using complexity theory to build interventions that improve health care delivery in primary care. J Gen Intern Med. 2006;21:S30-4.
38. Lanham HJ, McDaniel Jr RR, Crabtree BF, Miller WL, Stange KC, Tallia AF, et al. How improving practice relationships among clinicians and nonclinicians can improve quality in primary care. Jt Comm J Qual Patient Saf. 2009;35:457-66.
39. Tim W, Tim H. Complexity and clinical care. BMJ. 2001;323:685-8.
40. Anderson RA, Issel LM, McDaniel RR. Nursing homes as complex adaptive systems - Relationship between management practice and resident outcomes. Nurs Res. 2003;52:12-21.
41. Miller WL, Crabtree B, McDaniel R, Stange K. Practice Jazz Understanding variation in family practices using complexity science. J Family Pract. 2001;50:872-8.
42. Cars O, Högber LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. BMJ. 2008;337:a1438.
43. Leibovici L, Paul M, Ezra O. Ethical dilemmas in antibiotic treatment. J Antimicrob Chemother. 2012;67:12-6. 2011;6:12-22.
44. Moelstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125-32.
45. Bloom G, Henson S, Peters DH. Innovation in regulation of rapidly changing health markets. Glob Health. 2014;10:53.
46. Zhang X, Bloom G, Xu X, Chen L, Liang X, Wolcott SJ. Advancing the application of systems thinking in health: managing rural China health system development in complex and dynamic context. Health Research Policy and Systems. 2014;12:44.
47. Fang J. The Chinese health care regulatory institutions in an era of transition. Soc Sci Med. 2008;66:952-62.
48. Research group of Economy Institute in National Development and Reform Commission. The situation and problem of medicine producing and circulation in China. Jing Ji Yan Jiu Can Kao. 2014;31:4-27.
49. Meng Q, Yang H, Chen W, Sun Q, Liu X. People's Republic of China Health System Review (Health Systems in Transition, Vol. 5 No. 7. Geneva: World Health Organization (WHO); 2015.
50. China Food and Drug Adnimistration(CFDA): 2015 Yearbook of CFDA. http://www.sda.gov.cn/WS01/CL0108/143640.html. Accessed 15 Apr 2016.
51. National Health and Family Planning Commission(NHFPC): The number of health facilities by the end of 2014. http://www.nhfpc.gov.cn/mohwsbwst/s7967/201501/1e39cfd2159d426c8e46e29280dbd7f9.shtml. Accessed 31 May 2015.
52. Wan Q, Zhang Y, Wang X, Zhai T, Wang C, Chai P, et al. Results and Analysis of China National Health Accounts in 2013. Zhong Guo Wei Sheng Jing Ji. 2013;34(3):5-8.
53. Shan N, Fu H. The Impact of the natioanl essential medicines policy on the rational use of antibiotics in primary health facilities in China. Wei Sheng Ruan Ke Xue. 2011;25:782-5.
54. Yang C, Yang S, Yang L, Zhang X. The Impact of the national essential medicines policy on the rational use of antibiotics in primary health facilities in China. Zhong Guo Wei Sheng Shi Ye Guan Li. 2014;2:109-12.
55. Jin C, Yang H, Liang X, Wu N, Li Z, Chen L. the Impact of evaluation of essential medicine policies on joint usage of antibiotic, steroids and intravenous infusion in township health care. Zhong Guo Wei Sheng Jing Ji. 2013;32:53-5.
56. Song Y, Bian Y, Petzold M, Li L, Yin A. The impact of China's national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces. BMC Health Serv Res. 2014;14:507.
57. Gu X. How to reform health insurance payment system. Zhong Guo Yi Liao Bao Xian. 2011;11:12-5.
58. Hu X, Huang W. Analysis on the Obstacles to the Medical Insurance Payment Mechanism Reform. Zhong Guo Wei Sheng Jing Ji. 2015;34(1):19-23.
59. Yao K, Shen X, Yang Y. A brief introduction to the second national workshop on rational use of antibiotics in China. Zhong Hua Er Ke Za Zhi. 2006;44:318.
60. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: An exploratory analysis. Health Policy. 2009;90:32-6.
61. Jiang M, Wang L, Wang W, Wang X, Fang Y, Yang S, et al. Comparative study on the price and availability of essential drugs in public hospital and retail pharmacy of Shaanxi province. Zhong Guo Yao Fang. 2013;24:308-13.
62. China Food and Drug Adnimistration(CFDA): Notice about reinforcing the supercision of antibacterial drug selling in the retail pharmacy and promoting rational drug use. 2003. http://www.sda.gov.cn/WS01/CL0055/10126.html. Accessed 25 Oct 2015.
63. Jiang M, Fang Y, Chen W, Yang S, Liu J. Hou h, et al. Status quo on prescription antibiotics in retail pharmacies of Shanxi Province. Zhong Guo Wei Sheng Zheng Ce Yan Jiu. 2013;6:40-5.
64. Yu M, Zhu Y, Song X, Yang L, Tang T. Insights to residents' behaviours of antibiotic purchasing from medicinal sales data of retail pharmacies in rural China. Fu Dan Xue Bao (Yi Xue Ban). 2013;40:254-9.
65. Fang Y, Chen W, Yang S, Hou H, Jiang M. Analysis of antibiotics sale without prescription in pharmacies in West China -taking Xi'an as an example. Zhong Gong Wei Sheng Shi Ye Guan Li. 2012;3:184-7.
66. Jiang H, Ni Y. To push forward pharmaceutical care in retail drugstores in the background of new-health-carereform. Nan Jing Yi Ke Da Xue Xuebao (She Hui Ke Xue Ban). 2011;4:292-4.
67. Dégardin K, Roggo Y, Margot P. Understanding and fighting the medicine counterfeit market. J Pharm Biomed Anal. 2014;87:167-75.
68. Dong Z, Yang P. Selling Fake Drugs Through the Internet. Theory Res. 2012;32:141-2.
69. Xinhua News Agency. China busts counterfeit drug racket. 2011. http://www.chinadaily.com.cn/bizchina/2011-2/30/content_14356808.htm. Accessed 17 Oct 2015.
70. Yu M, Zhao G, Lundborg CS, Zhu Y, Zhao Q, Xu B. Knowledge, attitudes, and practices of parents in rural China on the use of antibiotics in children: a cross-sectional study. BMC Infect Dis. 2014;14:112.
71. Lv B, Zhou Z, Xu G, Yang D, Wu L, Shen Q, et al. Knowledge, attitudes and practices concerning self-medication with antibiotics among university students in western China. Trop Med Int Health. 2014;19:769-79.